GlassScriptPhysician profile
S Allison C Strnad
NPI 1962590067
$3,451.08
in general payments reported to CMS, 2019-2025
30 companies · $402 in 2025
The $402 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.21 · 2020: $66.70 · 2021: $683 · 2022: $657 · 2023: $574 · 2024: $1,003 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,879 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,879.43 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $585.17 | 2021-2024 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $448.71 | 2021-2024 | Ova1 |
| Astellas Pharma US INC | $383.19 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $329.09 | 2021-2024 | |
| Exeltis, USA INC. | $286.21 | 2021-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $215.46 | 2020-2025 | |
| Organon LLC | $149.94 | 2021-2025 | Nexplanon |
| Medtronic, INC. | $145.22 | 2023-2024 | V-Loc 180, Truclear |
| Hologic Sales and Service, LLC | $108.29 | 2021-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Omni Hysteroscope |
| Coopersurgical, INC. | $105.75 | 2019-2025 | Endosee, Paragard T 380a, Ally II Ups |
| Biogen, INC. | $94.24 | 2024 | Zurzuvae |
| Millicent US INC | $87.66 | 2022-2025 | Intrarosa, Femlyv |
| Mayne Pharma Commercial LLC | $79.77 | 2021-2022 | |
| Exact Sciences Corporation | $52.09 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $43.11 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $41.04 | 2021 | |
| Mylan Pharmaceuticals INC. | $35.79 | 2021-2022 | |
| Agile Therapeutics, INC. | $33.26 | 2021 | |
| Ascend Therapeutics US, LLC | $30.00 | 2020 | |
| Sanofi Pasteur INC. | $28.15 | 2025 | |
| Evofem Biosciences, INC. | $27.59 | 2021-2022 | |
| Mycovia Pharmaceuticals, INC. | $23.39 | 2023 | Vivjoa |
| Trevena, INC. | $18.43 | 2021 | |
| Becton, Dickinson and Company | $17.60 | 2020 | |
| Smith+Nephew, INC. | $16.92 | 2025 | Pico |
| Merck Sharp & Dohme LLC | $15.97 | 2021 | |
| Sumitomo Pharma America, INC. | $13.90 | 2025 | Myfembree |
| Allergan, INC. | $13.79 | 2019 | |
| Avion Pharmaceuticals | $13.14 | 2021 | |
| Meditrina | $8.21 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw S Allison Strnad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.